APYX Apyx Medical Corporation
USHealthcareAs of 2026-07-10 16:00
Why APYX matters now
Apyx Medical Corporation (APYX) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.38 with -1.79% on the session and $183.6M in market capitalization; recent performance reads 1-month +4.31% and YTD +17.43%.
The latest financial table shown here is Q1 2026, with revenue of $12.5M, net income of $-2.1M, and EPS of $-0.05. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -5.2%.
The latest indexable market news headline is "Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $6.00; recent insider activity includes Roman Shawn David filing M-Exempt. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
13.50
P/S
3.08
EV/EBITDA
-73.85
DCF Value
$-4.96
FCF Yield
-5.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
32.3%
Operating Margin
-7.7%
Net Margin
-16.4%
ROE
-90.6%
ROA
-14.5%
ROIC
-8.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $12.5M | $-2.1M | $-0.05 |
| Q4 2025 | $19.2M | $-1.3M | $-0.03 |
| FY 2025 | $52.8M | $-11.2M | $-0.27 |
| Q3 2025 | $12.9M | $-2.0M | $-0.05 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.39
Apyx Medical Corporation, an energy technology firm established in 1982 and headquartered in Clearwater, Florida, focuses on the development, manufacturing, and global sale of medical devices for both the aesthetic and surgical fields. The company operates through two main divisions: Advanced Energy and Original Equipment Manufacturing (OEM). Among its key innovations is the Helium Plasma Generator, which delivers a controlled combination of RF energy and helium to precisely cut, coagulate, and ablate soft tissue in open and laparoscopic surgical procedures. For the cosmetic surgery market, Apyx Medical offers its Renuvion product line, enabling plastic surgeons and other aesthetic practitioners to apply targeted heat for desired patient outcomes. Concurrently, the J-Plasma brand caters specifically to the hospital surgical sector. Furthermore, the company designs, produces, and sells disposable hand pieces, alongside OEM generators and their related accessories. The entity was previously known as Bovie Medical Corporation, changing its name to Apyx Medical Corporation in January 2019.